31 – 40 of 104
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2015
-
Mark
EndoS and EndoS2 hydrolyze Fc-glycans on therapeutic antibodies with different glycoform selectivity and can be used for rapid quantification of high-mannose glycans.
(
- Contribution to journal › Article
- 2014
-
Mark
EndoS Reduces the Pathogenicity of Anti-mCOL7 IgG through Reduced Binding of Immune Complexes to Neutrophils.
(
- Contribution to journal › Article
-
Mark
EndoE from Enterococcus faecalis Hydrolyzes the Glycans of the Biofilm Inhibiting Protein Lactoferrin and Mediates Growth.
(
- Contribution to journal › Article
-
Mark
Fcγ Receptors III and IV Mediate Tissue Destruction in a Novel Adult Mouse Model of Bullous Pemphigoid.
(
- Contribution to journal › Article
-
Mark
Bacterial glycosidases in pathogenesis and glycoengineering.
(
- Contribution to journal › Scientific review
- 2013
-
Mark
Human Chemokines as Antimicrobial Peptides with Direct Parasiticidal Effect on Leishmania mexicana In Vitro.
(
- Contribution to journal › Article
-
Mark
The protective effect of immunoglobulin in murine tuberculosis is dependent on IgG glycosylation
(
- Contribution to journal › Article
-
Mark
The carbohydrate switch between pathogenic and immunosuppressive antigen-specific antibodies.
(
- Contribution to journal › Article
-
Mark
EndoS2 is a unique and conserved enzyme of serotype M49 group A Streptococcus that hydrolyses N-linked glycans on IgG and α1-acid glycoprotein
(
- Contribution to journal › Article
-
Mark
Dominant suppression of inflammation by glycan-hydrolyzed IgG [Retracted]
(
- Contribution to journal › Article